Abstract
Cyclin D1 is a critical component of the core cell cycle machinery. Mice lacking cyclin D1 develop mammary glands that fail to undergo normal lobuloalveolar proliferation during pregnancy. Thus, cyclin D1 seems to play a critical role in pregnancy-induced proliferation of mammary epithelium. Cyclin D1 also participates in neoplasia, as the majority of human mammary carcinomas contain elevated levels of this cyclin.
Similar content being viewed by others
REFERENCES
C. J. Sherr (1994). G1 phase progression: cycling on cue. Cell 79:551–555.
R. A. Weinberg (1995). The retinoblastoma protein and cell cycle control. Cell 81:323–330.
T. Motokura, T. Bloom, H. Goo-Kim, H. Jüppner, J. V. Ruderman, H. M. Kronenberg, and A. Arnold (1991). A novel cyclin encoded by a bcll-linked candidate oncogene. Nature 350:512–515.
C. L. Rosenberg, H. G. Kim, T. B. Shows, H. M. Kronenberg, and A. Arnold (1991). Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. Oncogene 6:449–453.
C. L. Rosenberg, E. Wong, E. M. Petty, A. E. Bale, Y. Tsujimoto, N. L. Harris, and A. Arnold (1991). PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc. Natl. Acad. Sci. U.S.A. 88:9638–9642.
D. A. Withers, R. C. Harvey, J. B. Faust, O. Melnyk, K. Carey, T. C. Meeker (1991). Characterization of a candidate bcl-1 gene. Mol. Cell. Biol. 11:4846–4853.
T. Motokura and A. Arnold (1993). Cyclin D1 and oncogenesis. (1993). Curr. Opin. Gen. Devel. 3:5–10.
C. Dickson, V. Fantl, C. Gillett, S. Brookes, J. Bartek, R. Smith, C. Fisher, D. Barnes, and G. Peters (1995). Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer. Cancer Lett. 90:43–50.
G. A. Lammie, V. Fantl, R. Smith, E. Schuuring, S. Brookes, R. Michalides, C. Dickson, A. Arnold, and G. Peters (1991). D11S237, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 6:439–444.
M. F. Buckley, K. J. E. Sweeney, J. A. Hamilton, R. L. Sini, D. L. Manning, R. I. Nicholson, A. deFazio, C. K. W. Watts, E. A. Musgrove, and R. L. Sutherland (1993). Expression and amplification of cyclin genes in human breast cancer. Oncogene 8:2127–2133.
J. Bartkova, J. Lukas, H. Müller, D. Lützhoft, M. Strauss, and J. Bartek (1994). Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer 57:353–361.
J. Bartkova, J. Lukas, M. Strauss, and J. Bartek (1995). Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene 10:775–778.
C. Gillett, V. Fantl, R. Smith, C. Fisher, J. Bartek, C. Dickson, D. Barnes, and G. Peters (1994). Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res. 54:1812–1817.
C. Gillett, P. Smith, W. Gregory, M. Richards, R. Millis, G. Peters, and D. Barnes (1996). Cyclin D1 and prognosis in human breast cancer. Int. J. Cancer 69:92–99.
G. G. McIntosh, J. J. Anderson, I. Milton, M. Steward, A. H. Parr, M. D. Thomas, J. A. Henry, B. Angus, T. W. J. Lennard, and C. H. W. Horne (1995). Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene 11:885–891.
D. Weinstat-Saslow, M. J. Merino, R. E. Manrow, J. A. Lawrence, R. F. Bluth, K. D. Wittenbel, J. F. Simpson, D. L. Page, and P. S. Steeg (1995). Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nat. Med. 1:1257–1260.
R. Michalides, P. Hageman, H. van Tinteren, L. Houben, E. Wientjens, R. Klopmaker, and J. Peterse (1996). A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Brit. Med. J. 73:728–734.
T. C. Wang, R. D. Cardiff, L. Zukerberg, E. Lees, A. Arnold, and E. V. Schmidt (1994). Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669–671.
W. J. Muller, F. S. Lee, C. Dickson, G. Peters, P. Pattengale, and P. Leder (1990). The int-2 gene product acts as an epithelial growth factor in transgenic mice. EMBO J. 9:907–913.
R. M. L. Zwijsen, R. Klopmaker, E. B. H. G. M. Wientiens, P. M. P. Kristel, B. van den Burg, and R. J. A. M. Michalides (1996). Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit. Mol. Cell. Biol. 16:2554–2560.
E. A. Musgrove, C. S. Lee, M. F. Buckley, and R. L. Sutherland (1994). Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc. Natl. Acad. Sci. U.S.A. 91:8022–8026.
E. A. Musgrove, B. Sarcevic, and R. L. Sutherland (1996). Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for cdk2 activation and pRB hyperphosphorylation. J. Cell. Biochem. 60:363–378.
J. Lukas, J. Bartkova, and J. Bartek (1996). Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin dependent kinase-pRb-controlled G1 checkpoint. Mol. Cell. Biol. 16:6917–6925.
D. M. G. Resnitzky, H. Bujard, and S. I. Reed (1994). Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14:1669–1679.
P. Sicinski, J. Liu Donaher, S. B. Parker, T. Li, A. Fazeli, H. Gardner, S. Z. Haslam, R. T. Bronson, S. J. Elledge, and R. A. Weinberg (1995). Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621–630.
V. Fantl, G. Stamp, A. Andrews, I. Rosewell, and C. Dickson (1995). Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Devel. 9:2364–2372.
S. Z. Haslam (1988a). Acquisition of estrogen-dependent progesterone receptors by normal mouse mammary gland. Ontogeny of mammary progesterone receptors. J. Steroid Biochem. 31:9–13.
S. Z. Haslam (1988b). Progesterone effects on deoxyribonucleic acid synthesis in normal mouse mammary glands. Endocrinology 122:464–470.
S. Wang, L. J. Counterman, and S. Z. Haslam (1990). Progesterone action in normal mouse mammary gland. Endocrinology 127:2183–2189.
S. W. Tam, A. M. Theodoras, J. W. Shay, G. F. Draetta, and M. Pagano (1994). Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for Cyclin D1 function in G1 progression. Oncogene 9:2663–2674.
L. Altucci, R. Addeo, L. Cicatiello, S. Dauvois, M. G. Parker, M. Truss, M. Beato, V. Sica, F. Bresciani, and A. Weisz (1996). 17β-estadiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G1-arrested human breast cancer cells. Oncogene 12:2315–2324.
R. M. L. Zwijsen, E. Wientjens, R. Klopmaker, J. van der Sman, R. Bernards, and R. J. A. M. Michalides (1997). CDK-independent activation of estrogen receptor by cyclin D1. Cell 88:405–415.
J. F. Savouret, A. Bailly, M. Misrahi, C. Rauch, G. Redeuilh, A. Chauchereau, and E. Milgrom (1991). Characterization of the hormone responsive element involved in the regulation of the progesterone receptor gene. EMBO J. 10:1875–1883.
S. Nandi (1958). Endocrine control of mammary-gland development and function in the C3H/He Crgl mouse. J. Natl. Cancer Inst. 21:1040–1051.
C. J. Ormandy, N. Binart, and P. A, Kelly (1997). Mammary gland development in prolactin receptor knockout mice. J. Mam. Gland Biol. Neoplasia 2:355–364.
L. Henninghausen, G. W. Robinson, K.-V. Wagner, and X. Liu (1997). Developing a mammary gland in a stat affair. J. Mam. Gland Biol. Neoplasia 2:365–372.
P. Sicinski, J. Liu Donaher, Y. Geng, S. B. Parker, H. Gardner, M. Y. Park, R. L. Robker, J. S. Richards, L. K. McGinnis, J. D. Biggers, J. J. Eppig, R. T. Bronson, S. J. Elledge, and R. A. Weinberg (1996). Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 384:470–474.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sicinski, P., Weinberg, R.A. A Specific Role for Cyclin D1 in Mammary Gland Development. J Mammary Gland Biol Neoplasia 2, 335–342 (1997). https://doi.org/10.1023/A:1026391128117
Issue Date:
DOI: https://doi.org/10.1023/A:1026391128117